Cargando…

High antigen density of BCMA: friend or foe to CAR T cells?

Detalles Bibliográficos
Autores principales:	Gaballa, Mahmoud R, Maus, Marcela V
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2022
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9511652/ https://www.ncbi.nlm.nih.gov/pubmed/36137650 http://dx.doi.org/10.1136/jitc-2022-005822

Ejemplares similares

Anti-TACI single and dual-targeting CAR T cells overcome BCMA antigen loss in multiple myeloma
por: Larson, Rebecca C., et al.
Publicado: (2023)

Sphingolipids: Friends or Foes?
por: Hayashi, Hiroshi
Publicado: (2022)

Steering CAR T cells to distinguish friend from foe
por: Caruso, Hillary G., et al.
Publicado: (2018)

Driving CARs to new places: locally produced BCMA CAR T cells to treat multiple myeloma
por: Sjöstrand, Maria, et al.
Publicado: (2023)

CAR density influences antitumoral efficacy of BCMA CAR T cells and correlates with clinical outcome
por: Rodriguez-Marquez, Paula, et al.
Publicado: (2022)

Substance P—Friend or Foe
por: Robinson, Prema, et al.
Publicado: (2022)

Oxygen: both friend and foe
por: Purvis, J
Publicado: (2018)

Oral Bacteria: Friends and Foes?
por: He, Jinzhi, et al.
Publicado: (2023)

Anti-BCMA CAR T-cell Therapy: Changing the Natural History of Multiple Myeloma
por: Puertas, Borja, et al.
Publicado: (2022)

The VDD ICD lead: Friend or Foe?
por: Mittal, Suneet
Publicado: (2020)

Food in Chronic Pain: Friend or Foe?
por: Fifi, Amanda C., et al.
Publicado: (2020)

Inhaled Corticosteroids and Bronchiectasis: Friend or Foe?
por: Martinez-Garcia, Miguel Angel
Publicado: (2023)

Pareidolia—Friend or Foe in the Echo Lab?
por: Sorrell, Vincent L.
Publicado: (2023)

Fluid Therapy from Friend to Foe
por: Fodor, Raluca
Publicado: (2023)

Teclistamab impairs detection of BCMA CAR-T cells
por: Glatte, Bettina, et al.
Publicado: (2023)

CAR-T-Cell Therapy in Multiple Myeloma: B-Cell Maturation Antigen (BCMA) and Beyond
por: Mishra, Abhinava K., et al.
Publicado: (2023)

CRTH2 in Pulmonary Fibrosis: Friend or Foe?
por: He, Chao, et al.
Publicado: (2022)

Hypoxia and Sleep-disordered Breathing: Friend or Foe?
por: Eckert, Danny J., et al.
Publicado: (2022)

Humans and Other Animals—Future Friends or Foe?
por: Phillips, Clive J. C.
Publicado: (2012)

The Hippo pathway and cancer immunity: friend or foe?
por: Janse van Rensburg, Helena J, et al.
Publicado: (2018)

Artificial intelligence: is it a friend or foe of physicians?
Publicado: (2019)

Arousability in Obstructive Sleep Apnea: Friend or Foe?
por: Leung, Richard S.
Publicado: (2019)

Glucocorticoids in COVID19; a friend not foe
por: Owlia, Sina, et al.
Publicado: (2020)

Administrative Data for Palliative Care Research: Friend or Foe?
por: Courtright, Katherine R., et al.
Publicado: (2022)

ZEB Proteins in Leukemia: Friends, Foes, or Friendly Foes?
por: Soen, Bieke, et al.
Publicado: (2018)

Anti-BCMA CAR-T cells therapy for a patient with extremely high membrane BCMA expression: a case report
por: Li, Dan, et al.
Publicado: (2022)

Comparison of FACS and PCR for Detection of BCMA-CAR-T Cells
por: Reichman, Avinoam, et al.
Publicado: (2022)

Reactive Oxygen Species: Friends and Foes of Signal Transduction
por: Retta, Saverio Francesco, et al.
Publicado: (2012)

The up-rise in e-cigarette use – friend or foe?
por: Lundbäck, Bo, et al.
Publicado: (2016)

Data analysis in medical research: from foe to friend
por: K. Hackenberger, Branimir
Publicado: (2019)

Apolipoprotein E in Asthmatic Inflammatory Response: Friend or Foe?
por: Qin, Shugang, et al.
Publicado: (2020)

False Tendon in Cardiovascular Diseases: Friend, Foe, or Bystander?
por: Kim, Mi-Jeong
Publicado: (2021)

sBCMA Plasma Level Dynamics and Anti-BCMA CAR-T-Cell Treatment in Relapsed Multiple Myeloma
por: Seipel, Katja, et al.
Publicado: (2022)

Friend and Foe
Publicado: (1890)

Oncogene addiction and immune escape: friends or foes?
por: Abdayem, Pamela, et al.
Publicado: (2020)

γδT Cells in Lung Cancer Malignant Pleural Effusion: Friend? Foe?
por: Moon, Edmund K.
Publicado: (2019)

Toll-like receptor 4 in COVID-19: friend or foe?
por: Mukherjee, Suprabhat
Publicado: (2022)

Calcium and vitamin D in the serrated neoplastic pathway: Friends or foes?
por: García-Morales, Natalia, et al.
Publicado: (2018)

Fibroblast Growth Factor Inhibitors in Lung Fibrosis: Friends or Foes?
por: Guzy, Robert
Publicado: (2020)

Special Issue “Equine Viruses”: Old “Friends” and New Foes?
por: Paillot, Romain
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_rc19mv5i9hh542i7ujpgs87ofg